Zobrazeno 1 - 10
of 25
pro vyhledávání: '"E Saffouri"'
Autor:
J Pugmire, Keith Siau, U Basavaraju, E Saffouri, Allan J. Morris, Mhairi C Donnelly, Adrian J. Stanley
Publikováno v:
Posters.
Introduction The 2015 NCEPOD report ‘Time to Get Control’ highlighted the need to improve the quality of care of patients with acute upper GI bleeding (AUGIB). The BSG Endoscopy Quality Improvement Project created an evidence based care bundle fo
Publikováno v:
Oesophagus.
Introduction In the UK, radiofrequency ablation (RFA) is established as treatment of choice for flat oesophageal neoplasia or after removal of focal lesions by endoscopic mucosal resection (EMR) to eradicate Barrett’s mucosa. Standard practice is t
Autor:
Cher Shiong Chuah, Gareth-Rhys Jones, Jennifer Veryan, Shahida Din, Nikolas Plevris, Mathew Lyons, P. Shasi, Angus Watson, John Todd, E. Saffouri, A Sengupta, Paul Brennan, Graham Naismith, M Groome, L Potts, Antonia M. D. Churchhouse, R. M. Allen, Philip Jenkinson, E. Donoghue, Craig Mowat, Daniel R. Gaya, W. L. Lam, S. Chaudhary, H. Jafferbhoy, Morag Jane MacMaster, David Watts, John Paul Seenan, I. D. R. Arnott, Diarmid Ian Sutherland, Charlie W. Lees, Jonathan Macdonald
Publikováno v:
Journal of Crohn'scolitis. 13(9)
Background & Aims Vedolizumab is an anti-a4b7 monoclonal antibody that is licensed for the treatment of moderate to severe Crohn’s disease and ulcerative colitis. The aims of this study were to establish the real-world effectiveness and safety of v
Autor:
Daniel R. Gaya, P Shasi, D Watts, Charlie W. Lees, P Baker, H Jafferbhoy, C Mowat, Emma Donoghue, John Paul Seenan, Andrea K Watson, Graham Naismith, E Saffouri, Morag MacMaster, John Todd, Nikolas Plevris, Max Groome, Phil Jenkinson, L Potts, Cher Chuah, Alan G. Shand, Colin L. Noble, Antonia M. D. Churchhouse, Jonathan Macdonald, Eleanor F Watson, J Veryan, A Sengupta, Paul Brennan, Shahida Din, R Allen, I. D. R. Arnott, G R Jones
Publikováno v:
IBD.
Introduction The GEMINI trials and an increasing body of real-world data have demonstrated the effectiveness and safety of vedolizumab (VDZ) in IBD. However, there is limited available data about its effect on hospitalisations and steroid use. Our ai
Publikováno v:
Small Bowel.
Introduction Postoperative ileal Crohns disease remains a significant challenge in terms of prevention and treatment once recognised. Many such patients have often lost response to previous anti-TNF exposure prior to surgical intervention and as such
Publikováno v:
Liver.
Introduction Liver disease is the fifth most common cause of death in the UK. 1 Patients with chronic liver disease (CLD) and its complications present frequently to hospital; when their disease reaches end-stage, their supportive and palliative care
Autor:
C Mowat, M MacMaster, C S Chuah, E Saffouri, G Jones, P Baker, D Watts, R Allen, John Todd, A Sengupta, Andrea K Watson, A Churchhouse, N Plevris, Graham Naismith, Max Groome, E. Donoghue, L Potts, P Shasi, P Brennan, Daniel R. Gaya, Charles Lees, Ian Arnott, John Paul Seenan, J Veryan, Jonathan Macdonald, P Jenkinson, H Jafferbhoy
Publikováno v:
Journal of Crohn's and Colitis. 12:S306-S306
Autor:
E. Saffouri, Simon Ogston, Iain S. Tait, P. Sanjay, Christoph Kulli, Francesco M. Polignano, J. Moore
Publikováno v:
The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland. 8(3)
Background There is minimal data on the outcome of early laparoscopic cholecystectomy (LC) for acute gallbladder disease when performed by trainees. This study assesses the outcomes of a policy of same admission LC incorporated into a surgical traini
Publikováno v:
Canadian Journal of Cardiology. 31:S134
Publikováno v:
Gut. 64:A269.1-A269
Introduction Liver function tests (LFTs) are commonly measured upon admission to hospital. LFT derangement on admission not only prompts investigation of pathology but also predicts short-term mortality. Longer-term implications of short-term changes